This fits a model where triggering of CD38 receptor function leads to immediate lateral associations with proteins in the CLL membrane/BCR complex to drive pSyk activation, while downstream CD38 signaling would be responsible for gene regulatory effects (e.g., SPN and LGALS1). The gene discussed is SPN; the disease is B-cell chronic lymphocytic leukemia.